Lantheus Holdings (LNTH) Shares Outstanding (Diluted Average) (2015 - 2025)
Lantheus Holdings (LNTH) reported Shares Outstanding (Diluted Average) of $71.5 million for Q1 2025, up 1.95% year-over-year from $70.1 million in Q1 2024, and little changed quarter-over-quarter from $71.7 million in Q4 2024.
Lantheus Holdings (LNTH) Shares Outstanding (Diluted Average) (2015 - 2025) Analysis & Trends
Lantheus Holdings (LNTH) has 11 years of Shares Outstanding (Diluted Average) data on file, last reported at $71.5 million in Q1 2025.
- Shares Outstanding (Diluted Average) for Q1 2025 came in at $71.5 million, up 1.95% year-over-year; the trailing twelve-month figure through Mar 2025 was $71.5 million (up 1.95% YoY), and the FY2024 annual result was $71.7 million, up 2.01% from the prior year.
- Shares Outstanding (Diluted Average) was little changed at $71.5 million in Q1 2025 per LNTH's latest filing, from $71.7 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $73.1 million in Q3 2024 and troughed at $67.5 million in Q4 2021.
- A 5-year average of $69.8 million and a median of $70.1 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Diluted Average) surged 68.85% in 2021, then dropped 3.29% in 2023.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $67.5 million in 2021, then climbed by 4.72% to $70.7 million in 2022, then decreased by 0.61% to $70.2 million in 2023, then rose by 2.01% to $71.7 million in 2024, then declined by 0.27% to $71.5 million in 2025.
- Business Quant data shows LNTH's Shares Outstanding (Diluted Average) at $71.5 million in Q1 2025, $71.7 million in Q4 2024, and $73.1 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 101.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 71.46 Mn |
| Dec 31, 2024 | 71.65 Mn |
| Sep 30, 2024 | 73.07 Mn |
| Jun 30, 2024 | 70.36 Mn |
| Mar 31, 2024 | 70.10 Mn |
| Dec 31, 2023 | 70.24 Mn |
| Sep 30, 2023 | 70.05 Mn |
| Jun 30, 2023 | 69.96 Mn |
| Mar 31, 2023 | 67.75 Mn |
| Dec 31, 2022 | 70.67 Mn |
| Sep 30, 2022 | 70.67 Mn |
| Jun 30, 2022 | 70.80 Mn |
| Mar 31, 2022 | 70.05 Mn |
| Dec 31, 2021 | 67.49 Mn |
| Sep 30, 2021 | 67.62 Mn |
| Jun 30, 2021 | 67.51 Mn |
| Mar 31, 2021 | 67.71 Mn |
| Dec 31, 2020 | 54.13 Mn |
| Sep 30, 2020 | 49.86 Mn |
| Jun 30, 2020 | 43.14 Mn |